How It Works
Mesenchymal Stem Cell Therapy uses umbilical cord-derived mesenchymal stem cells to support the body’s natural healing response through regenerative signaling, promoting tissue repair and reducing inflammation.
Regenerative Medicine & Orthobiologics
Advanced Regenerative Medicine for Joint Pain & Tissue Healing
A non-surgical approach using umbilical cord-derived mesenchymal stem cells to support the body’s natural healing response, reduce pain, and improve mobility.
Why patients choose us
Care built around you
- Umbilical cord-derived mesenchymal stem cells
- Physician-performed, ultrasound-guided precision
- Supports tissue repair without surgery
- Personalized plan based on your diagnosis and goals
- Regular follow-up to monitor healing progress
Our Expertise
What this service includes
Ultrasound-Guided Delivery
Every treatment is performed using real-time ultrasound guidance to ensure accurate, personalized placement.
Minimally Invasive
Performed in-office — no surgery, no general anesthesia, with most patients returning to light activity quickly.
How It Works
Five steps to relief
Comprehensive Consultation
Your physician reviews your symptoms, medical history, previous treatments, and long-term recovery goals.
Imaging & Diagnosis
MRI, X-rays, ultrasound, or other diagnostic imaging are evaluated to identify the source of your condition.
Customized Treatment Plan
Therapy is designed around your diagnosis, activity level, and health goals.
Ultrasound-Guided Therapy
Real-time ultrasound guidance ensures precise delivery to the targeted area. Most treatments are completed in less than one hour.
Recovery & Follow-Up
Most patients return to daily activities quickly, with follow-up visits to monitor healing progress.
Conditions Treated
What this therapy is used for
- Knee osteoarthritis
- Hip osteoarthritis
- Shoulder arthritis
- Chronic tendon injuries
- Ligament injuries
- Persistent joint pain
- Sports injuries
- Inflammation management
Treatment Includes
What’s included
- Comprehensive orthopedic evaluation
- Review of diagnostic imaging
- Personalized regenerative medicine plan
- Ultrasound-guided precision treatment
- Physician-performed procedure
- Follow-up care and recovery monitoring
Pricing
- Initial consultation & imaging review
- $300
- Treatment starting from
- $2,500
The consultation fee is credited toward treatment. Pricing varies based on the treatment plan and physician recommendations. These are self-pay services and are not covered by insurance or Medicare.
Book a ConsultationPatient Guide & Answers
Common questions
What is Mesenchymal Stem Cell Therapy?
A regenerative medicine treatment that uses umbilical cord-derived mesenchymal stem cells selected for their regenerative signaling properties to support the body’s natural healing response.
Who is a good candidate?
Candidacy is determined after a comprehensive consultation, medical history review, physical examination, and imaging assessment.
Is the procedure surgical?
No — it’s a minimally invasive treatment performed in the office using ultrasound guidance.
How long does the procedure take?
Most treatments are completed in less than one hour, allowing many patients to return to light activity quickly.
How soon will I notice improvement?
Recovery varies for every patient. Some begin noticing improvement within weeks; others see gradual progress over the following months.
Why choose RegenOrtho Palm Beach?
The practice combines experienced physicians, advanced imaging technology, and personalized regenerative medicine treatment plans.
Support Healing, Skip the Surgery
Find out if mesenchymal stem cell therapy fits your recovery goals — consultation and imaging review is $300, credited toward treatment starting from $2,500.
Important Medical Information
None of the therapies described are FDA-approved to treat, cure or prevent any disease or condition, and they are not a substitute for indicated surgical care. Composition and mechanism characteristics are drawn from published literature and supplier documentation, not from RegenOrtho Palm Beach outcomes. Cellular products are HCT/Ps from accredited U.S. suppliers; per 21 C.F.R. § 1271.3(d) cell factors such as RPA are not classified as HCT/Ps. Donors are U.S.-based, screened and tested by third-party CLIA laboratories. Individual results vary and no outcome is guaranteed. This material is general education, not medical advice. Services are self-pay and are not covered by insurance or Medicare.